The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations

Hendrée E. Jones, Lauren M Jansson, Kevin E. O'Grady, Karol Kaltenbach

Research output: Contribution to journalArticle

Abstract

Compared to untreated opioid dependence, methadone maintenance treatment of opioid-dependent pregnant women has been found to be associated with better maternal and neonatal outcomes. Secondary analysis of data from 73 maternal and neonatal participants in the MOTHER study (H. E. Jones et al., New England Journal of Medicine, 2010) found no relationship between maternal methadone dose at delivery and any of 9 neonatal outcomes - peak neonatal abstinence syndrome (NAS) score, total amount of morphine needed to treat NAS, duration of neonatal hospital stay, duration of treatment for NAS, estimated gestational age at delivery, Apgar score at 5. min, and neonatal head circumference, length, and weight at birth. These results are consistent with a recent systematic review and meta-analysis (B. J. Cleary et al., Addiction, 2010) and extend findings to outcomes other than NAS. Methodological and design issues that might have adversely impacted the ability of researchers to establish the existence or non-existence of these relationships are considered.

Original languageEnglish (US)
Pages (from-to)110-115
Number of pages6
JournalNeurotoxicology and Teratology
Volume39
DOIs
StatePublished - Sep 2013

Fingerprint

Neonatal Abstinence Syndrome
Methadone
Opioid Analgesics
Mothers
Morphine
Medicine
New England
Aptitude
Apgar Score
Birth Weight
Gestational Age
Meta-Analysis
Pregnant Women
Length of Stay
Head
Research Personnel
Therapeutics

Keywords

  • Methadone
  • Neonatal abstinence syndrome
  • Neonate
  • Opioid dependence
  • Pregnancy

ASJC Scopus subject areas

  • Developmental Neuroscience
  • Cellular and Molecular Neuroscience
  • Toxicology

Cite this

The relationship between maternal methadone dose at delivery and neonatal outcome : Methodological and design considerations. / Jones, Hendrée E.; Jansson, Lauren M; O'Grady, Kevin E.; Kaltenbach, Karol.

In: Neurotoxicology and Teratology, Vol. 39, 09.2013, p. 110-115.

Research output: Contribution to journalArticle

@article{8f52df52599d4bbfbef280eff5ae8605,
title = "The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations",
abstract = "Compared to untreated opioid dependence, methadone maintenance treatment of opioid-dependent pregnant women has been found to be associated with better maternal and neonatal outcomes. Secondary analysis of data from 73 maternal and neonatal participants in the MOTHER study (H. E. Jones et al., New England Journal of Medicine, 2010) found no relationship between maternal methadone dose at delivery and any of 9 neonatal outcomes - peak neonatal abstinence syndrome (NAS) score, total amount of morphine needed to treat NAS, duration of neonatal hospital stay, duration of treatment for NAS, estimated gestational age at delivery, Apgar score at 5. min, and neonatal head circumference, length, and weight at birth. These results are consistent with a recent systematic review and meta-analysis (B. J. Cleary et al., Addiction, 2010) and extend findings to outcomes other than NAS. Methodological and design issues that might have adversely impacted the ability of researchers to establish the existence or non-existence of these relationships are considered.",
keywords = "Methadone, Neonatal abstinence syndrome, Neonate, Opioid dependence, Pregnancy",
author = "Jones, {Hendr{\'e}e E.} and Jansson, {Lauren M} and O'Grady, {Kevin E.} and Karol Kaltenbach",
year = "2013",
month = "9",
doi = "10.1016/j.ntt.2013.05.003",
language = "English (US)",
volume = "39",
pages = "110--115",
journal = "Neurotoxicology and Teratology",
issn = "0892-0362",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - The relationship between maternal methadone dose at delivery and neonatal outcome

T2 - Methodological and design considerations

AU - Jones, Hendrée E.

AU - Jansson, Lauren M

AU - O'Grady, Kevin E.

AU - Kaltenbach, Karol

PY - 2013/9

Y1 - 2013/9

N2 - Compared to untreated opioid dependence, methadone maintenance treatment of opioid-dependent pregnant women has been found to be associated with better maternal and neonatal outcomes. Secondary analysis of data from 73 maternal and neonatal participants in the MOTHER study (H. E. Jones et al., New England Journal of Medicine, 2010) found no relationship between maternal methadone dose at delivery and any of 9 neonatal outcomes - peak neonatal abstinence syndrome (NAS) score, total amount of morphine needed to treat NAS, duration of neonatal hospital stay, duration of treatment for NAS, estimated gestational age at delivery, Apgar score at 5. min, and neonatal head circumference, length, and weight at birth. These results are consistent with a recent systematic review and meta-analysis (B. J. Cleary et al., Addiction, 2010) and extend findings to outcomes other than NAS. Methodological and design issues that might have adversely impacted the ability of researchers to establish the existence or non-existence of these relationships are considered.

AB - Compared to untreated opioid dependence, methadone maintenance treatment of opioid-dependent pregnant women has been found to be associated with better maternal and neonatal outcomes. Secondary analysis of data from 73 maternal and neonatal participants in the MOTHER study (H. E. Jones et al., New England Journal of Medicine, 2010) found no relationship between maternal methadone dose at delivery and any of 9 neonatal outcomes - peak neonatal abstinence syndrome (NAS) score, total amount of morphine needed to treat NAS, duration of neonatal hospital stay, duration of treatment for NAS, estimated gestational age at delivery, Apgar score at 5. min, and neonatal head circumference, length, and weight at birth. These results are consistent with a recent systematic review and meta-analysis (B. J. Cleary et al., Addiction, 2010) and extend findings to outcomes other than NAS. Methodological and design issues that might have adversely impacted the ability of researchers to establish the existence or non-existence of these relationships are considered.

KW - Methadone

KW - Neonatal abstinence syndrome

KW - Neonate

KW - Opioid dependence

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84885030119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885030119&partnerID=8YFLogxK

U2 - 10.1016/j.ntt.2013.05.003

DO - 10.1016/j.ntt.2013.05.003

M3 - Article

C2 - 24099621

AN - SCOPUS:84885030119

VL - 39

SP - 110

EP - 115

JO - Neurotoxicology and Teratology

JF - Neurotoxicology and Teratology

SN - 0892-0362

ER -